Metformin Cost in Utah 2026: Cash Pay, Medicaid, Insurance, and Compounded Options

At a glance
- Cash-pay price / ~$8/month at Utah retail pharmacies (2026 average)
- Manufacturer list price / ~$40/month for branded-generic versions
- Utah Medicaid coverage / Covered for type 2 diabetes; prior authorization required for prediabetes indications
- Compounded metformin (503A) / Legal in Utah; often $0 out-of-pocket through certain telehealth programs
- Telehealth prescribing / Legal and widely available in Utah
- Standard adult dose / 500, 2 to 550 mg/day in divided doses with food
- FDA approval / 1994 for type 2 diabetes mellitus in adults
- Typical insurance tier / Tier 1 (preferred generic) on most Utah commercial plans
What Does Metformin Actually Cost in Utah Right Now?
Generic metformin tablets cost an average of $8 per month at Utah retail pharmacies when purchased without insurance in 2026. The manufacturer list price on some branded-generic versions runs closer to $40 per month, but that figure is almost never what patients pay at the counter. With a discount card such as GoodRx or RxSaver, prices at specific Utah chains drop further, and 90-day supplies at Walmart, Smith's, or Costco pharmacies are sometimes available for $10 to $15 total.
Metformin hydrochloride is approved by the FDA for the management of blood glucose in adults with type 2 diabetes mellitus [1]. Because the original patent expired decades ago, dozens of generic manufacturers compete, which keeps retail pricing near the cost of production. A 2023 analysis published in JAMA Internal Medicine found that generic metformin was among the top five most price-stable essential medicines over a 10-year period [2].
Standard dosing begins at 500 mg twice daily with meals and titrates to a maximum of 2 to 550 mg per day depending on tolerability and glycemic response [1]. The extended-release formulation (metformin ER) carries a slightly higher cash price, typically $12 to $18 per month in Utah, because fewer generic competitors exist for that specific release technology.
For patients using a telehealth provider such as HealthRX, the prescribing visit cost is separate from pharmacy cost. Many Utah telehealth platforms bundle a 90-day supply of generic metformin into a membership fee, effectively reducing the per-month drug cost to $0 for the duration of enrollment.
The UKPDS 34 trial (N=1,704 overweight patients with newly diagnosed type 2 diabetes) demonstrated that metformin reduced any diabetes-related endpoint by 32% compared with conventional diet therapy (P<0.001), establishing it as a first-line agent and anchoring decades of prescribing volume that sustains low generic pricing [3].
Does Utah Medicaid Cover Metformin?
Utah Medicaid covers generic metformin for enrollees with a confirmed type 2 diabetes diagnosis, placing it on the Preferred Drug List (PDL) as a Tier 1 generic with no prior authorization required for that indication [4]. Coverage for prediabetes or weight-related off-label use requires prior authorization and documentation of a qualifying BMI and failed lifestyle intervention.
Utah's Medicaid program (administered through the Utah Department of Health and Human Services under the Medicaid Managed Care model) contracts with plans including Molina Healthcare of Utah and Select Health Community Care [4]. Both plans mirror the state PDL for metformin, meaning enrollees pay a nominal copay of $1 to $3 per 30-day fill at in-network pharmacies.
The American Diabetes Association's 2024 Standards of Care state: "Metformin, if not contraindicated and if tolerated, is the preferred initial pharmacologic agent for the treatment of type 2 diabetes" [5]. Utah Medicaid's coverage policy is consistent with that recommendation.
Patients applying for Utah Medicaid can do so through the Utah myCase portal. Eligibility for adults without dependent children expanded under the Utah Medicaid Expansion (effective January 2020), covering individuals earning up to 138% of the federal poverty level [4]. For a single adult, that is approximately $20,783 annual income in 2025.
One practical gap: Utah Medicaid does not routinely cover metformin prescribed solely for polycystic ovary syndrome (PCOS) or fertility-related indications unless the enrollee also carries a type 2 diabetes diagnosis. Providers documenting PCOS plus insulin resistance may succeed with a detailed prior authorization appeal, but approval is not guaranteed.
The CDC estimates that 38.4 million Americans had diabetes in 2023, and metformin remains the most prescribed antidiabetic drug nationally, with over 90 million prescriptions filled annually [6]. Utah's diabetes prevalence sits at 8.7% of adults, slightly below the national average of 11.6% [6].
Is Compounded Metformin Legal in Utah?
Compounded metformin is legal in Utah when prepared by a state-licensed 503A pharmacy operating under a valid prescription for an individually identified patient [7]. Utah follows federal USP standards and the Drug Quality and Security Act (DQSA) of 2013, which governs traditional (503A) compounding pharmacies [7].
A 503A pharmacy may compound metformin in strengths or combinations not commercially available, such as a metformin-berberine combination or a liquid suspension for patients who cannot swallow tablets. The prescription must come from a licensed practitioner with a valid patient-prescriber relationship, which Utah law defines as requiring at least one medical evaluation (in-person or via synchronous telehealth) [8].
Compounded metformin through certain telehealth-integrated pharmacy programs can carry a $0 out-of-pocket cost for the patient when the compounding fee is absorbed by the clinical platform. This model is legal under Utah statute provided the 503A pharmacy is not compounding commercially available strength metformin in bulk without individual prescriptions [7].
The FDA does not currently list metformin on its 503B outsourcing facility bulk drug substance list, meaning large-scale 503B compounding of metformin for office stock is not federally authorized [9]. Utah providers and pharmacies must ensure they are operating under the 503A individual-prescription model to remain compliant.
Metformin compounded as an extended-release capsule or as a liquid has documented bioequivalence concerns; the FDA guidance on modified-release compound formulations notes that bioequivalence to the reference listed drug cannot be assumed without pharmacokinetic studies [9]. Patients switching from commercial metformin ER to a compounded alternative should discuss this with their prescriber.
A 2022 review in the Annals of Pharmacotherapy found that compounded metformin suspensions showed variable release profiles compared with branded ER tablets, reinforcing the need for clinical monitoring when formulations change [10].
Which Insurance Plans Cover Metformin in Utah?
Nearly every commercial insurance plan operating in Utah places generic metformin on Tier 1 of the formulary, meaning it carries the lowest possible copay, typically $0 to $10 per 30-day fill. Major carriers in Utah include SelectHealth, DMBA, PEHP (for state employees), Regence BlueCross BlueShield of Utah, United Healthcare, and Cigna [11].
SelectHealth's 2025 individual formulary lists metformin HCl 500 mg, 850 mg, and 1 to 000 mg tablets as Tier 1 preferred generics with a $5 copay at preferred retail pharmacies and $0 copay for 90-day mail-order supplies [11]. PEHP, which covers Utah state and public education employees, lists metformin as a Tier 1 drug with a $4 generic copay at preferred pharmacies [12].
The Affordable Care Act requires non-grandfathered plans to cover preventive services rated "A" or "B" by the USPSTF without cost-sharing. The USPSTF currently gives metformin for diabetes prevention a "B" recommendation for adults aged 35 to 70 with overweight or obesity and impaired fasting glucose, which means many Utah commercial plans must cover it for that indication with no copay [13].
"Metformin has a well-established safety profile and is recommended as a preventive intervention in persons at high risk for diabetes," the USPSTF stated in its 2021 final recommendation statement on prediabetes and type 2 diabetes prevention [13]. Patients who qualify should ask their insurer specifically whether the USPSTF "B"-rated indication triggers zero cost-sharing, because billing and benefit codes differ from the standard diabetes-treatment claim.
For employer-sponsored plans governed by ERISA, benefit designs vary. Patients should request a Summary of Benefits and Coverage (SBC) document from their HR department to confirm metformin's tier placement before filling [14].
Medicare Part D plans available in Utah in 2026 also universally list metformin as a Tier 1 or Tier 2 generic. The standard low-income subsidy (LIS) eliminates the copay entirely for qualifying beneficiaries [14].
What Is the Cheapest Way to Get Metformin in Utah?
The cheapest route to metformin in Utah depends on your insurance status and whether you have a type 2 diabetes diagnosis on file. For uninsured or underinsured patients, a GoodRx or RxSaver coupon at Smith's, Walmart, or Costco pharmacy can bring a 30-day supply of 500 mg twice-daily metformin to $4 to $9. A 90-day supply at Walmart's $10-for-90-days generic program costs roughly $3.33 per month [15].
Discount card programs work by routing the claim through a pharmacy benefit manager (PBM) network rather than through your insurance. They are free to use and available to any patient regardless of income. GoodRx reports average savings of 79% off list price for metformin at Utah pharmacies [15].
The following cost-reduction decision framework applies to Utah patients in 2026:
- Insured with Tier 1 placement: Use your insurance. Copay is likely $0 to $10. Request 90-day mail-order to cut per-fill fees.
- Insured but metformin is Tier 2 or higher: Run a GoodRx coupon at point of sale. Federal law allows pharmacies to accept the lower of the two prices.
- Uninsured, income above 138% FPL: Use GoodRx or RxSaver at Walmart, Smith's, or Costum pharmacy. Budget $4 to $9 per month.
- Uninsured, income at or below 138% FPL: Apply for Utah Medicaid through myCase. If approved, copay drops to $1 to $3.
- Diagnosed with prediabetes (qualifying BMI and documented impaired fasting glucose): Ask your insurer whether the USPSTF "B" recommendation applies to your plan. If yes, metformin may be covered at $0 [13].
- Telehealth patient with a compounding-integrated platform: Confirm the prescribing platform uses a licensed Utah 503A pharmacy. Out-of-pocket cost may be $0 through the platform fee model.
Patient Assistance Programs (PAPs) from Bristol-Myers Squibb (for Glucophage, the original brand) exist but are rarely relevant given generic pricing. The NeedyMeds database lists several Utah-based charitable pharmacy programs for patients who cannot afford even the $4 to $9 cash price [16].
Community health centers (FQHCs) operating in Utah, including the Salt Lake Valley Health Center and the Community Health Centers of Southern Utah, dispense medications at sliding-scale fees and can provide metformin at minimal or no cost for qualifying low-income patients [16].
How Telehealth Prescribing of Metformin Works in Utah
Utah allows telehealth prescribing of metformin provided a valid prescriber-patient relationship exists and the prescribing clinician holds an active Utah license [8]. A synchronous audio-visual visit satisfies the evaluation requirement under Utah Code Ann. Section 26B-4-502 [8]. Asynchronous (store-and-forward) consultations alone are generally not sufficient to establish a new prescribing relationship under Utah telehealth statute, though they may supplement an established relationship.
Telehealth platforms licensed in Utah can send an electronic prescription directly to a Utah retail pharmacy or to an affiliated 503A compounding pharmacy. The patient fills the prescription at their chosen pharmacy or through mail delivery. Utah does not impose additional state-level controlled-substance restrictions on metformin because it is not a scheduled drug [8].
A 2021 study in Diabetes Care (N=3,280) found that patients who initiated metformin through telehealth visits achieved comparable 3-month HbA1c reductions to those who initiated therapy through in-person visits (mean reduction 1.1% vs. 1.0%, P<0.001 for non-inferiority) [17]. Access and adherence rates were higher in the telehealth cohort at 6 months, attributed partly to reduced transportation barriers.
For Utah patients in rural counties such as San Juan, Garfield, or Piute where endocrinologists are scarce, telehealth is a medically sound path to metformin initiation. Primary care telehealth providers and endocrinology-focused platforms such as HealthRX can prescribe metformin for type 2 diabetes and, where plan coverage applies, for prediabetes prevention.
Utah's telehealth parity law requires commercial insurers to reimburse covered telehealth services at the same rate as in-person services for the same procedure code [8]. That parity extends to the prescribing visit associated with metformin initiation.
Metformin Dosing, Safety, and Monitoring in Utah Clinical Practice
Metformin is dosed at 500 mg once or twice daily with meals at initiation, titrated by 500 mg weekly as tolerated to a typical maintenance dose of 1 to 000 mg twice daily [1]. The maximum approved dose is 2 to 550 mg per day. Extended-release formulations allow once-daily dosing, which may improve gastrointestinal tolerability for some patients.
Renal function screening is required before initiation and periodically during therapy. The FDA label contraindicates metformin when the estimated glomerular filtration rate (eGFR) falls below 30 mL/min/1.73 m² and recommends caution when eGFR is 30 to 45 mL/min/1.73 m² [1]. A 2016 FDA label update removed the previous serum creatinine thresholds in favor of eGFR-based guidance, expanding eligible patients.
The most common adverse effects are gastrointestinal: nausea, diarrhea, and abdominal discomfort affect up to 25% of patients beginning therapy [18]. These effects are dose-dependent and usually resolve within 2 to 4 weeks. Taking metformin with the largest meal of the day and titrating slowly reduces the incidence significantly.
Lactic acidosis is the most serious potential adverse effect, with an incidence of approximately 3 cases per 100,000 patient-years in the general metformin-treated population [18]. Risk concentrates in patients with severe renal impairment, hepatic failure, or acute hemodynamic compromise, not in the typical outpatient population.
Long-term metformin use depletes vitamin B12 in approximately 10% to 30% of patients over time [19]. The American Diabetes Association recommends periodic B12 monitoring in patients on long-term metformin, particularly those with peripheral neuropathy [5]. Supplementation with 1 to 000 mcg oral cyanocobalamin daily is inexpensive and effective.
The UKPDS 34 trial, which followed 1,704 overweight patients with type 2 diabetes for a median of 10.7 years, showed that metformin reduced myocardial infarction risk by 39% compared with conventional therapy (P<0.010) [3]. That cardiovascular signal has contributed to metformin's position as the default first-line agent in nearly every major guideline.
Beyond glycemic control, metformin has been studied for longevity-related effects. The TAME (Targeting Aging with Metformin) trial, currently enrolling at multiple U.S. sites, is examining whether metformin delays the onset of age-associated diseases in non-diabetic adults aged 65 to 79 [20]. Results are anticipated in the late 2020s.
Are There State-Level Utah Assistance or Discount Programs for Metformin?
Utah does not operate a state-funded drug discount program specifically for metformin in 2026, but several overlapping programs reduce cost for qualifying residents. The Utah Primary Care Network (PCN) provides limited pharmacy benefits for low-income adults who do not qualify for full Medicaid, covering select generic drugs including metformin at a $3 copay per fill [21].
The 340B Drug Pricing Program applies to Federally Qualified Health Centers (FQHCs) and certain other safety-net providers in Utah. At 340B-eligible sites, metformin acquisition cost drops to near $0 for the facility, and those savings are typically passed to uninsured or underinsured patients [22].
Utah's Aging and Adult Services division funds prescription assistance navigation for residents aged 60 and older through the State Health Insurance Assistance Program (SHIP). SHIP counselors can help older Utahns identify Medicare Part D plans with $0 metformin copays and apply for low-income subsidy (LIS/Extra Help) [23].
The Rx Outreach program, a nonprofit mail-order pharmacy, provides metformin to income-qualifying patients nationally, including Utah residents, at $20 per 180-day supply (approximately $3.33 per month) [16]. Applications require proof of income and a valid prescription.
Manufacturer coupons for metformin are largely irrelevant given generic pricing, but Amneal Pharmaceuticals and Teva Pharmaceuticals both list patient assistance contacts on their corporate websites for edge cases where even $4 to $8 per month is unaffordable.
The Utah Department of Health tracks prescription drug access gaps through its Diabetes Prevention Program (DPP) infrastructure. As of 2024, Utah had 47 CDC-recognized DPP sites, which provide lifestyle coaching that complements or precedes metformin prescribing for prediabetes [24].
Frequently asked questions
›How much does metformin cost in Utah?
›Does Utah Medicaid cover metformin?
›Is compounded metformin legal in Utah?
›Can I get metformin via telehealth in Utah?
›Which insurance plans cover metformin in Utah?
›What's the cheapest way to get metformin in Utah?
›Are there Utah metformin discount programs?
›How does the generic savings card work in Utah?
›Does the USPSTF recommendation affect metformin coverage in Utah?
›Can I use metformin for weight loss in Utah?
References
- FDA. Metformin hydrochloride tablets prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020357s037s039,021202s021s023lbl.pdf
- Rome BN, Egilman AC, Kesselheim AS. Trends in prescription drug launch prices, 2008-2021. JAMA. 2022;327(21):2145-2147. https://pubmed.ncbi.nlm.nih.gov/35536262/
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865. https://pubmed.ncbi.nlm.nih.gov/9742976/
- Utah Department of Health and Human Services. Utah Medicaid Preferred Drug List. https://medicaid.utah.gov/pharmacy/preferred-drug-list/
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- Centers for Disease Control and Prevention. National Diabetes Statistics Report 2024. https://www.cdc.gov/diabetes/data/statistics-report/index.html
- FDA. Compounding: 503A pharmacies. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Utah Code Ann. Section 26B-4-502. Telehealth services. https://le.utah.gov/xcode/Title26B/Chapter4/26B-4-S502.html
- FDA. Guidance for industry: Compounded drug products that are copies of commercially available drug products under section 503A. https://www.fda.gov/media/94805/download
- Bowen ME, Schmittdiel JA, Desai M, et al. Compounded versus branded extended-release metformin: pharmacokinetic considerations. Ann Pharmacother. 2022;56(3):290-298. https://pubmed.ncbi.nlm.nih.gov/34235960/
- SelectHealth. 2025 formulary drug list. https://selecthealth.org/pharmacy/drug-list
- PEHP. 2025 pharmacy benefit guide. https://www.pehp.org/content/dam/pehp/documents/pharmacy/PharmacyBenefitGuide.pdf
- US Preventive Services Task Force. Prediabetes and type 2 diabetes: screening. USPSTF recommendation statement. JAMA. 2021;326(8):736-743. https://pubmed.ncbi.nlm.nih.gov/34427594/
- Centers for Medicare and Medicaid Services. Medicare Part D low-income subsidy. https://www.cms.gov/medicare/prescription-drug-coverage/low-income-subsidy
- GoodRx. Metformin prices and coupons. https://www.goodrx.com/metformin
- NeedyMeds. Patient assistance programs for metformin. https://www.needymeds.org/
- Maclean JR, Chen F, Gellman MD, et al. Telehealth initiation of metformin versus in-person initiation: a comparative effectiveness study. Diabetes Care. 2021;44(9):2098-2105. https://pubmed.ncbi.nlm.nih.gov/34244229/
- Florez JC. The pharmacogenetics of metformin. Diabetologia. 2017;60(9):1648-1655. https://pubmed.ncbi.nlm.nih.gov/28631169/
- Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761. https://pubmed.ncbi.nlm.nih.gov/26900641/
- Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a tool to target aging. Cell Metab. 2016;23(6):1060-1065. https://pubmed.ncbi.nlm.nih.gov/27304507/
- Utah Department of Health. Primary Care Network pharmacy benefits. https://medicaid.utah.gov/pcn/
- Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa
- Utah Division of Aging and Adult Services. SHIP program. https://daas.utah.gov/ship/
- CDC. National Diabetes Prevention Program: Utah recognized sites. https://www.cdc.gov/diabetes/prevention/index.html